For example, we previously reported that granular tau oligomers appear before tau fibril formation and that an inhibitor of tau aggregation blocks the formation of granular tau and prevents neuronal loss in a mouse model of tauopathy (Soeda et al., 2015). The gene discussed is MAPT; the disease is tauopathy.